Tumor-Specific MHC-II Activates CD4+ and CD8+ T cells in Head and Neck Squamous Cell Carcinoma to Boost Immunotherapy Efficacy.
- Journal:
- Cancer Research
- Published:
- Affiliations:
- 3
- Authors:
- 9
| Institutions | Authors | Share |
|---|---|---|
| Wuhan University (WHU), China | 0.78 | |
| Renmin Hospital of Wuhan University/Hubei General Hospital, China | 0.11 | |
| Hospital of Stomatology, WHU, China | 0.11 |